Acasti Pharma Inc Share Price Toronto S.E.
Equities
APO
CA00430K1057
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CAD | - |
28/05 | Acasti Pharma Inc. to Attend BIO International Convention 2024 | CI |
12/02 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 39.56M 28.72M 2.4B |
---|---|---|---|---|---|
Net income 2024 * | -18M -13.07M -1.09B | Net income 2025 * | -23M -16.7M -1.4B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.18
x | P/E ratio 2025 * |
-2.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.98% |
Latest transcript on Acasti Pharma Inc
Managers | Title | Age | Since |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 01/21/01 |
Director of Finance/CFO | 52 | 05/01 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 08/23/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 10/23/10 |
Director/Board Member | - | 10/23/10 | |
Santosh Kottayil
BRD | Director/Board Member | - | 10/23/10 |
1st Jan change | Capi. | |
---|---|---|
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- ACST Stock
- APO Stock